Biotech Values

[theordore]

RE. M&A has been the music -- since the longevity of this music is an issue, it would be helpful to have a list of the firms that will likely have good organic growth to keep reported earnings at decent levels as we go forward. I'm a Newbie to biotech. What hand-full of firms should I watch to keep my eyes focused on those that will likely still be looking good when the M&A music stops? Thanks.